Cover Image
Market Research Report

Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

Published by The Business Research Company Product code 959784
Published Content info 200 Pages
Delivery time: 2-3 business days
Price
Back to Top
Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery
Published: September 9, 2020 Content info: 200 Pages
Description

Antiglaucoma Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antiglaucoma drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antiglaucoma Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Product Type: Alpha Agonist; Beta Blockers; Prostaglandin Analogs; Combined Medication; Others

2) By Disease Condition Type: Open-Angle Glaucoma; Angle-Closure Glaucoma; Normal-Tension Glaucoma; Congenital Glaucoma; Other Types Of Glaucoma

3) By Type: Hospital Prescription drugs; Over-the counter drugs

Companies Mentioned: Aerie Pharmaceuticals; ALLERGAN; Novartis AG; Abbott Healthcare; Johnson & Johnson

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Table of Contents

1. Executive Summary

2. Antiglaucoma Drugs Market Characteristics

3. Antiglaucoma Drugs Market Size And Growth

  • 3.1. Global Antiglaucoma Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Antiglaucoma Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Antiglaucoma Drugs Market Segmentation

  • 4.1. Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Alpha Agonist
    • Beta Blockers
    • Prostaglandin Analogs
    • Combined Medication
    • Others
  • 4.2. Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Open-Angle Glaucoma
    • Angle-Closure Glaucoma
    • Normal-Tension Glaucoma
    • Congenital Glaucoma
    • Other Types Of Glaucoma
  • 4.3. Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospital Prescription drugs
    • Over-the counter drugs

5. Antiglaucoma Drugs Market Regional And Country Analysis

  • 5.1. Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Antiglaucoma Drugs Market

  • 6.1. Asia-Pacific Antiglaucoma Drugs Market Overview
  • 6.2. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Antiglaucoma Drugs Market

  • 7.1. China Antiglaucoma Drugs Market Overview
  • 7.2. China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Antiglaucoma Drugs Market

  • 8.1. India Antiglaucoma Drugs Market Overview
  • 8.2. India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Antiglaucoma Drugs Market

  • 9.1. Japan Antiglaucoma Drugs Market Overview
  • 9.2. Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Antiglaucoma Drugs Market

  • 10.1. Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Antiglaucoma Drugs Market

  • 11.1. Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Antiglaucoma Drugs Market

  • 12.1. South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Antiglaucoma Drugs Market

  • 13.1. Western Europe Antiglaucoma Drugs Market Overview
  • 13.2. Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Antiglaucoma Drugs Market

  • 14.1. UK Antiglaucoma Drugs Market Overview
  • 14.2. UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Antiglaucoma Drugs Market

  • 15.1. Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Antiglaucoma Drugs Market

  • 16.4. France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Antiglaucoma Drugs Market

  • 17.1. Eastern Europe Antiglaucoma Drugs Market Overview
  • 17.2. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Antiglaucoma Drugs Market

  • 18.1. Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Antiglaucoma Drugs Market

  • 19.1. North America Antiglaucoma Drugs Market Overview
  • 19.2. North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Antiglaucoma Drugs Market

  • 20.1. USA Antiglaucoma Drugs Market Overview
  • 20.2. USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Antiglaucoma Drugs Market

  • 21.1. South America Antiglaucoma Drugs Market Overview
  • 21.2. South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Antiglaucoma Drugs Market

  • 22.1. Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Antiglaucoma Drugs Market

  • 23.1. Middle East Antiglaucoma Drugs Market Overview
  • 23.2. Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Antiglaucoma Drugs Market

  • 24.1. Africa Antiglaucoma Drugs Market Overview
  • 24.2. Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Antiglaucoma Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Antiglaucoma Drugs Market Competitive Landscape
  • 25.2. Antiglaucoma Drugs Market Company Profiles
    • 25.2.1. Aerie Pharmaceuticals, Inc
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. ALLERGAN
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis AG
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Abbott Healthcare
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Johnson & Johnson
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market

27. Antiglaucoma Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Antiglaucoma Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top